Estimating that ReNU2 syndrome could account for around 10 percent of recessive neurodevelopmental disorder cases with a ...

Genomic profiling enables therapy individualization when actionable mutations (FLT3, NPM1, IDH1/2, TP53) are present, moving ...

Explore the recent advances in fuzzing, including the challenges and opportunities it presents for high-integrity software ...

In this interview, Dr. Michelle Fraser highlights how base editing and AI-designed enzymes are expanding therapeutic ...

AI is transforming medicine by improving diagnostics, personalized treatments, and operational efficiency. Key opportunities ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

AI algorithms that can identify which patients are most likely to benefit from a drug recently backed for NHS use as a colorectal cancer (CRC) therapy have been developed by scien ...

The idea that modern humans inherited DNA from Neanderthal ancestors is one of the 21st century’s most celebrated discoveries ...

Explore how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale.

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...